المساهمون: Ali Aminian, Director of Bariatric and Metabolic Institute

المصدر: A Prospective Multicenter International Randomized Controlled Trial Comparing Surgical and Medical Therapies in the Treatment of Advanced Metabolic Dysfunction Associated Steatohepatitis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06374875Test

المصدر: FINErenone druG Utilization Study and Assessment of Temporal Changes Following Availability of Different Treatment Options in Patients With Chronic Kidney Disease and Type 2 Diabetes

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05526157Test

Other URLs: https://clinicaltrials.bayer.comTest/

المصدر: Comparative Cardiovascular and Renal Effectiveness and Safety of Empagliflozin and Other SGLT2i in Patients With Type 2 Diabetes (T2D) With and Without Baseline Kidney Disease in the United States

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05465317Test

Other URLs: https://www.mystudywindow.comTest

المؤلفون: Patient-Centered Outcomes Research Institute

المساهمون: Rozalina G. McCoy, Principal Investigator

المصدر: Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05214573Test

Other URLs: https://www.mayo.edu/research/clinical-trialsTest

المؤلفون: Hangzhou Sciwind Biosciences Co., Ltd.

المصدر: A Phase 2, Open-label, Randomised, Dose-Finding Study of XW003, Once-Weekly Human Glucagon-Like Peptide 1 Analogue, Compared With Once-Daily Liraglutide 3 mg in Adult Participants With Obesity

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05111912Test

المؤلفون: Guangdong Provincial People's Hospital, First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Henan University of Science and Technology

المساهمون: Zhiguang Zhou, Director of The National Clinical Research Center for Metabolic Diseases, and Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Endocrinology, The Second Xiangya Hospital of Central South University.

المصدر: A Randomized Controlled, Open-label, Multi-center Study With 16-week Beinaglutide or Dulaglutide Assessing Effects on Glucose Control and Weight Loss in Type 2 Diabetes With Overweight or Obesity.

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05005741Test

المؤلفون: Hangzhou Sciwind Biosciences Co., Ltd.

المصدر: A Phase 1, Randomised, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of XW003 Injection in Healthy Adult Participants

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04389775Test

المؤلفون: National Institute of Neurological Disorders and Stroke (NINDS)

المصدر: Effects of Exenatide on Motor Function and the Brain

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03456687Test

المصدر: Holden SE, Morgan CL, Qo Q, Jenks-Jones S, BernER, Curr CJ. Healthcare resource utatn and related fancl costs assocted wh glucose lowerg wh eher exenate or basal sul: A retrospecte cohort study. Dbetes Obes Metab. 2017 Aug;19(8):1097-1105. do 10.1111/dom.12916. Epub 2017 Mar 31.
Evaluation of the Clinical and Economic Outcomes Associated With Exenatide Versus Basal Insulin in People With Type 2 Diabetes

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02987348Test

Other URLs: http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4435&filename=D5551R00010_Poster_ADA2016.pdfTest

المساهمون: Christina Kruuse, MD, PhD, DMSc, consultant Neurologist, Associate Professor

المصدر: The Effect of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist on Cerebral Blood Flow Velocity in Stroke Patients

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02829502Test